Haplotype Labs Analysis: $500K Raised
What is Haplotype Labs?
Haplotype Labs develops SaaS technology to lower sequencing costs, predict and prevent diseases using polygenic risk models, and streamline processes by removing custom software pipelines.
Employees
1
Founded
2024
Investors
- Brainstorm Ventures
- Soma Capital
- Y Combinator
Product Features & Capabilities
- reduce sequencing costs by 50% - 90%, predict, detect, and prevent disease using polygenic risk models, streamline processes by eliminating bespoke software pipelines
How much Haplotype Labs raised
1 - $500,000
February 27, 2024Lead Investor: Saturnin Pugnet, Y Combinator
Who are the founders of Haplotype Labs
MP
Mike Polcari
Founder
Market Focus
Haplotype Labs primarily focuses on the biotechnology industry, specifically in the areas of genetic sequencing, disease prediction, and prevention through polygenic risk models, utilizing SaaS technology to enhance efficiency and reduce costs.
Business Model
SaaS platform generating revenue through subscriptions and partnerships with healthcare providers.
Competitors Overview
Haplotype Labs operates in the genomic SaaS market, focusing on reducing sequencing costs and predicting diseases through polygenic risk models. Its main competitors include:
- Strand Life Sciences: This company offers genomic data analysis and interpretation services, focusing on personalized
See something that needs updating? Suggest edits to this profile.